Camptosar irinotecan package insert
WebSep 26, 2024 · Camptosar Dosage Generic name: IRINOTECAN HYDROCHLORIDE 20mg in 1mL Dosage form: injection, solution Drug class: Miscellaneous antineoplastics Medically reviewed by Drugs.com. Last updated on Sep 26, 2024. Colorectal Cancer Combination Regimens 1 and 2 Administer CAMPTOSAR as a 90-minute intravenous … WebClick on the irinotecan (Camptosar) package insert link below for a complete list of reported side effects and possible drug interactions; Side Effect Videos Nausea and Vomiting Diarrhea Hair Loss Fatigue Pain Neutropenic Fever Blood Clots See DailyMed package insert. Share this page:
Camptosar irinotecan package insert
Did you know?
WebSep 6, 2024 · CAMPTOSAR should be administered as an intravenous infusion over 90 minutes. CAMPTOSAR Injection must be diluted prior to infusion. CAMPTOSAR should be diluted in 5% Dextrose Injection, USP, (preferred) or 0.9% Sodium Chloride Injection, USP, to a final concentration range of 0.12 to 2.8 mg/mL. WebThe concentrate contains 20 mg/ml irinotecan hydrochloride trihydrate (equivalent to 17.33 mg/ml irinotecan). Excipients: sorbitol, lactic acid and water for injections. The pH of the solution is adjusted to 3.5 with sodium hydroxide. Vials of CAMPTO contain 40 mg or 100 mg or 300 mg of irinotecan hydrochloride trihydrate. THERAPEUTIC INDICATIONS
WebAug 1, 1998 · ABSTRACT: Irinotecan (CPT-11 [Camptosar]) is an important new chemotherapeutic drug that demonstrates activity against a broad spectrum of malignancies, including carcinomas of the colon, stomach, and lung. ... Pharmacia & Upjohn: Irinotecan Package Insert. 59. Goncalves E, de Costa L, Abigerges D, et al: A new enkephalinase … WebIrinotecan hydrochloride trihydrate, CPT -11 COMMON TRADE NAME(S): CAMPTOSAR® CLASSIFICATION: Topoisomerase I inhibitor. Special pediatric considerations are noted when applicable, otherwise adult provisions apply. MECHANISM OF ACTION: Irinotecan is a semisynthetic, water -soluble derivative of camptothecin, which is a cytotoxic alkaloid ...
WebIn addition, homozygosity for *28 is specified as the primary risk factor in the Camptosar (irinotecan) package insert. 29 Consequently, we chose to limit the review of clinical validity to these ... WebThe CAMPTOSAR (irinotecan) package insert recommends a reduced initial dose be considered for patients homozygous for the UGT1A1*28 allele and are at an increased risk for neutropenia following initiation of CAMPTOSAR treatment. AutoGenomics Doc EM-34028E (English) Rev. I (CO 4027) May 2024
WebONIVYDE® (irinotecan liposome injection) + 5-FU/LV is the #1 prescribed and only FDA-approved metastatic pancreatic cancer treatment post-gemcitabine. Access efficacy, safety, and dosing information. Please see Important Safety Information and full prescribing information, including Boxed WARNING.
WebIrinotecan hydrochloride (HCL) is an antineoplastic drug that is a semisynthetic derivative of camptothecin, an alkaloid extract from plants. The drug works by causing strand breaks in DNA that the cell cannot repair leading to cell death. Irinotecan is FDA approved for the following indications: record keeping good practiceWeb3. How to use Irinotecan 4. Possible side effects 5. How to store Irinotecan 6. Contents of the pack and other information 1. What Irinotecan is and what it is used for Irinotecan hydrochloride 20 mg/ml concentrate for solution for infusion is an anticancer medicine containing the active substance irinotecan hydrochloride trihydrate. record keeping for s corpWebIrinotecan liposome injection (also known MM-398 and PEP02) is a liposomal formulation of the topoisomerase I inhibitor irinotecan. It is a nanotherapeutic agent that consists of 80,000 molecules of the chemotherapeutic irinotecan encapsulated in … unzip with password command linehttp://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Irinotecan_monograph.pdf record keeping for sharesWebIRINOTECAN Hydrochloride Injection, USP* Brand Name Equivalent: CAMPTOSAR®(CAMPTOSAR is a registered trademark of Yakult Honsha Company, Ltd.) Therapeutic Category: Antineoplastic Agent PreventIV Measures®Features: Easy-to-read drug name and dosage strength to aid in identifying the right product unzip with passwordWebIrinotecan (Camptosar) patient drug information (UpToDate) History of changes in FDA indication 6/14/1996: Initial accelerated approval for the treatment of patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following 5 … unzip with robocopyWebMay 11, 2024 · CAMPTOSAR is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. 2 DOSAGE AND ADMINISTRATION 2.1 Colorectal Cancer Combination Regimens 1 and 2 Administer CAMPTOSAR as a 90-minute intravenous infusion … unzip with password windows